Literature DB >> 27248769

Random start or emergency IVF/in vitro maturation: a new rapid approach to fertility preservation.

David Mark Robertson1,2, Robert B Gilchrist1, William Leigh Ledger1, Angela Baerwald3.   

Abstract

There is a need to develop rapid protocols for ovarian stimulation for women who wish to preserve their fertility following diagnosis of cancer. Conventional gonadotropin stimulation protocols are lengthy and are delayed until the start of the next menstrual period, potentially compromising cancer treatments. The development of random start IVF/in vitro maturation has made significant strides for enabling couples undergoing cancer therapy to achieve a family. However, several unanswered questions still remain. What do we know about the endocrinology of stimulating ovarian follicular activity outside the established protocols of stimulation during the follicular phase? This article explores what is known about antral follicle development during the menstrual cycle, novel ovarian stimulation proposals for optimizing assisted reproductive therapies in women, and direction.

Entities:  

Keywords:  FSH stimulation; IVM; folliculogenesis; letrozole

Mesh:

Year:  2016        PMID: 27248769      PMCID: PMC5384505          DOI: 10.2217/whe-2015-0001

Source DB:  PubMed          Journal:  Womens Health (Lond)        ISSN: 1745-5057


  49 in total

1.  Synchronization of ovarian stimulation with follicle wave emergence in patients undergoing in vitro fertilization with a prior suboptimal response: a randomized, controlled trial.

Authors:  Angela Baerwald; Paula Anderson; Albert Yuzpe; Allison Case; Margo Fluker
Journal:  Fertil Steril       Date:  2012-07-20       Impact factor: 7.329

2.  Luteal phase oocyte retrieval and in vitro maturation is an optional procedure for urgent fertility preservation.

Authors:  Ettie Maman; Dror Meirow; Masha Brengauz; Hila Raanani; Jehushua Dor; Ariel Hourvitz
Journal:  Fertil Steril       Date:  2010-08-05       Impact factor: 7.329

3.  Associations Between Antral Ovarian Follicle Dynamics and Hormone Production Throughout the Menstrual Cycle as Women Age.

Authors:  Heidi Vanden Brink; David Mark Robertson; Hyun Lim; Chel Lee; Donna Chizen; Guy Harris; Georgina Hale; Henry Burger; Angela Baerwald
Journal:  J Clin Endocrinol Metab       Date:  2015-10-14       Impact factor: 5.958

4.  Chromosome constitution of human embryos generated after in vitro maturation including 3-isobutyl-1-methylxanthine in the oocyte collection medium.

Authors:  C Spits; L Guzman; A Mertzanidou; K Jacobs; C Ortega-Hrepich; R B Gilchrist; J G Thompson; M De Vos; J Smitz; K Sermon
Journal:  Hum Reprod       Date:  2014-12-04       Impact factor: 6.918

5.  An ongoing pregnancy from two waves of follicles developing during a long follicular phase of the same cycle.

Authors:  Yaakov Bentov; Navid Esfandiari; Asli Gokturk; Eliezer Burstein; Ofer Fainaru; Robert F Casper
Journal:  Fertil Steril       Date:  2010-06       Impact factor: 7.329

6.  Effect of different gonadotrophin priming on IVM of oocytes from women with normal ovaries: a prospective randomized study.

Authors:  R Fadini; M B Dal Canto; M Mignini Renzini; F Brambillasca; R Comi; D Fumagalli; M Lain; M Merola; R Milani; E De Ponti
Journal:  Reprod Biomed Online       Date:  2009-09       Impact factor: 3.828

Review 7.  Oncofertility for gynecologic and non-gynecologic cancers: fertility sparing in young women of reproductive age.

Authors:  Polat Dursun; N Utku Doğan; Ali Ayhan
Journal:  Crit Rev Oncol Hematol       Date:  2014-07-22       Impact factor: 6.312

Review 8.  Fertility preservation in the female cancer patient.

Authors:  Lauren Ross; Karine Chung; Heather Macdonald
Journal:  J Surg Oncol       Date:  2014-10-03       Impact factor: 3.454

9.  Age-related changes in major ovarian follicular wave dynamics during the human menstrual cycle.

Authors:  Heidi Vanden Brink; Donna Chizen; Georgina Hale; Angela Baerwald
Journal:  Menopause       Date:  2013-12       Impact factor: 2.953

10.  Effect of hCG priming on embryonic development of immature oocytes collected from unstimulated women with polycystic ovarian syndrome.

Authors:  Xiaoying Zheng; Lina Wang; Xiumei Zhen; Ying Lian; Ping Liu; Jie Qiao
Journal:  Reprod Biol Endocrinol       Date:  2012-05-24       Impact factor: 5.211

View more
  6 in total

1.  Ovarian Stimulation Is Safe and Effective for Patients with Gynecologic Cancer.

Authors:  Ruba A Akel; Xiaoyue M Guo; Molly B Moravek; Rafael Confino; Kristin N Smith; Angela K Lawson; Susan C Klock; Edward J Tanner Iii; Mary Ellen Pavone
Journal:  J Adolesc Young Adult Oncol       Date:  2020-01-10       Impact factor: 2.223

2.  Thirteen years' experience in fertility preservation for cancer patients after in vitro fertilization and in vitro maturation treatments.

Authors:  Helene Creux; Patricia Monnier; Weon-Young Son; William Buckett
Journal:  J Assist Reprod Genet       Date:  2018-03-03       Impact factor: 3.412

3.  Specific protocols of controlled ovarian stimulation for oocyte cryopreservation in breast cancer patients.

Authors:  F Cavagna; A Pontes; M Cavagna; A Dzik; N F Donadio; R Portela; M T Nagai; L H Gebrim
Journal:  Curr Oncol       Date:  2018-12-01       Impact factor: 3.677

4.  Long-term outcomes in cancer patients who did or did not pursue fertility preservation.

Authors:  Molly B Moravek; Rafael Confino; Kristin N Smith; Ralph R Kazer; Susan C Klock; Angela K Lawson; William J Gradishar; Mary Ellen Pavone
Journal:  Fertil Steril       Date:  2018-01-17       Impact factor: 7.329

Review 5.  Oocyte in vitro maturation: A sytematic review.

Authors:  Şafak Hatırnaz; Barış Ata; Ebru Saynur Hatırnaz; Michael Haim Dahan; Samer Tannus; Justin Tan; Seang Lin Tan
Journal:  Turk J Obstet Gynecol       Date:  2018-06-21

6.  A specific controlled ovarian stimulation (COS) protocol for fertility preservation in women with breast cancer undergoing neoadjuvant chemotherapy.

Authors:  Felipe Cavagna; Anagloria Pontes; Mario Cavagna; Artur Dzik; Nilka F Donadio; Rafael Portela; Michelle T Nagai; Luiz H Gebrim
Journal:  Contemp Oncol (Pozn)       Date:  2017-12-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.